AIM: The “2026 Guideline for the Early Management of Patients With AIS” replaces the “2018 Guidelines for the Early Management of Patients With AIS” and the 2019 update to reflect recent advances in ...
PharmaEssentia Announces Updated NCCN Clinical Practice Guidelines Include ropeginterferon alfa-2b-njft (BESREMi®) for ...
In a significant shift for the treatment landscape of essential thrombocythemia (ET), the US National Comprehensive Cancer Network (NCCN) has designated ropeginterferon alfa-2b-njft (Besremi) as a ...
Over the past 20 years, courts have clarified that clinical practice guidelines are helpful but not definitive standards of care. They can be used by experts as part of their reasoning but are not ...
The American Society of Hematology (ASH) released guidelines on the diagnosis of light chain (AL) amyloidosis, a rare and life-threatening disease of the bone marrow. The guidelines, published in the ...
Correspondence to Dr Roula Kotsifaki, Rehabilitation Department, Aspetar Orthopaedic and Sports Medicine Hospital, Doha, Qatar; argyro.kotsifaki{at}aspetar.com This guideline was developed to inform ...
Phase I Trial of First-in-Class ATR Inhibitor M6620 (VX-970) as Monotherapy or in Combination With Carboplatin in Patients With Advanced Solid Tumors Based on a systematic review, an international ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results